Forbes

Houston Texans wide receiver Nico Collins, Baltimore Ravens WR Zay Flowers and Seattle Seahawks free safety Tyler Okada will all miss Week 2 due to hamstring injuries.

A doctor answers the most common questions about Legionnaires' disease amid the second outbreak in New York City.

Obesity, type 2 diabetes, fatty liver and heart disease are usually recognized long after a silent process has begun.

By remaining shrouded in mystery, the MFN deals agreed to with drug makers reveal too little to tell how much money they’ll save governments as well as taxpayers and patients.

Longtime ESPN and FOX Sports sidelines sportscaster Erin Andrews was diagnosed with cervical cancer in September 2016. Here's how it's changed her life since.

A doctor cites scientific evidence in fact-checking President Trump's Oval Office address on September 18, 2026 regarding vaccines and autism

Spaceships with tentacles. Designing an award-winning drug. How the Fed hiking rates will impact emerging tech. All that and more in this week’s Prototype.

Philanthropist Melinda French Gates discusses what the findings from a new Gallup-Pivotal survey reveal about the widespread gaps in women’s healthcare and how they impact women’s careers, family life, civic participation and more—and what it will take to build a healthcare system that better serves women throughout their lives.

Medicare costs are set to rise in 2027 as Part D spending accelerates and Medicare Advantage plans prepare major benefit cuts and fraud safeguards lag.

Health insurance costs rise again in 2027. A physician explains open enrollment deadlines, the ACA subsidy cliff, Medicare drug plan changes and what to check by Dec. 15.

Self-driving cars can restore transportation independence for spine patients with nerve problems—while raising hard questions about responsibility.

CVS Health’s Aetna will bundle cancer treatments into a single clinical review as the industry works to further eliminate the controversial prior authorization process.

Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. These stories and more in this week’s Forbes InnovationRx newsletter.

Global health cuts caused real damage, but innovation and determination by countries, communities and partners helped prevent even deeper setbacks.

Oscar Health plans to expand its individual and small business coverage offerings by 400 to 600 counties by 2029 as the health insurer has become more profitable.